Form 4 for CTNM Contineum Therapeutics, Inc.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001437749-26-004122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $1.01 | +400 | 156.5K | +0.3% | +$404 |
| D | 2026-02-13 | 2026-02-11 | CTNM | Lorrain Daniel S. | CSO | S - Sale+OE | $16.00 | -400 | 156.1K | -0.3% | -$6,400 |
| D | 2026-02-13 | 2026-02-11 | CTNM | Lorrain Daniel S. | CSO | M - OptEx | $0.00 | -400 | 75.5K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-11 | M | A | 400 | $1.01 | 156,452 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-02-11 | S | D | 400 | $16.00 | 156,052 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-11 | M | D | 400 | $0.00 | 75,530 | D | $1.01 · — to 2030-02-24 | 400 Class A Common Stock | (F2) The stock options are fully vested and exercisable. |